BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Prostate
,
Autoimmunity
,
Doxorubicin
,
rs2300478
,
FOXP1
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MDM2/MDM4 family protein binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Medulla
Hippocampus
Vestibular nuclei superior
Cerebral cortex
Dorsal root ganglia
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Mucopolysaccharidosis
Pyloric ulcer
Vesicular stomatitis Indiana virus disease
Ectrodactyly
Amelia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
flavopiridol
marinobufagenin
CGP 60474
KU 55933
chlorodibromomethane
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Mcs5
Stat5a
ZNF57
MAPK13
MTTP
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Liver Pharmacology and Xenobiotic Response Repertoire
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis.
Structure of human MDM4 N-terminal domain bound to a single-domain antibody.
Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for MDM2/MDM4 family protein binding
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ